661
Participants
Start Date
September 30, 2014
Primary Completion Date
December 31, 2016
Study Completion Date
December 31, 2016
Preimplantation Genetic Screening by NGS
The VeriSeq PGS takes advantage of next-generation sequencing (NGS) technology to provide comprehensive, accurate screening of all 24 chromosomes for selection of euploid embryos.
Melbourne IVF, Melbourne
Main Line Fertility, Bryn Mawr
Reproductive Associates of Delaware, Newark
Georgia Reproductive Specialists, Atlanta
CRM Orlando, Orlando
IVF Michigan, Bloomfield Hills
Fertility Center of Illinois, Highland Park, Highland Park
The Advanced IVF Institute, Naperville
Dallas IVF, Frisco
Dallas Fertility Center, Dallas
Houston Fertility Institute, Houston
CORM Houston, Webster
Texas Fertility Center, Austin
Colorado Center for Reproductive Medicine (CCRM), Lonetree
Utah Fertility Center, Pleasant Grove
Reproductive Care Center, Sandy City
Fertility Treatment Center, Tempe
HRC Fertility Pasadena, Pasadena
HRC Fertility, Encino
Fertility Specialists Medical Group, San Diego
Acacio Fertility Clinic, Laguna Niguel
Reproductive Science Center of San Francisco Bay Area, San Ramon
Fertility Institute of Hawaii, Honolulu
Seattle Reproductive Medicine, Seattle
IVF New England, Lexington
Genesis Genetics (USA) - Genetics Laboratory, Plymouth
Genesis Genetics (UK) - Genetics Laboratory, London
Reprogenetics (UK) - Genetics Laboratory, Oxford
Reproductive Science Center of New Jersey, Eatontown
Reprogenetics (USA) - Genetics Laboratory, Livingston
IRMS at St. Barnabas, Livingston
Olive Fertility Centre, Vancouver
Reproductive Care Center, Mississauga
TRIO Fertility Treatment Practice, Toronto
Boston Place Clinic, London
Care Fertility Group London, London
Care Fertility Group Manchester, Manchester
Oxford Fertility Unit, Oxford
Lead Sponsor
Collaborators (2)
Reprogenetics
INDUSTRY
Genesis Genetics
OTHER
Illumina, Inc.
INDUSTRY